Role of antimalarials in rheumatoid arthritis - The British experience

Lupus

Volumn 5, Issue SUPPL. 1, 1996, Pages

  Davis, M J ^a   Woolf, A D ^a  

^a Duke of Cornwall Rheumatology Unit   (United Kingdom)

Author keywords

Antimalarials; Efficacy; Rheumatoid arthritis; Toxicity

Indexed keywords

ANALGESIC AGENT; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; EYE TOXICITY; HUMAN; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; UNITED KINGDOM;

EID: 0029991841     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203396005001091     Document Type: Article

References (22)

1. Page F. Treatment of lupus erythematosus with mepacrine. Lancet 1951; 2: 755.
2. Haydu GG, Rheumatoid arthritis therapy: rationale and use of chloroquine diphosphate. Am J Med Sci 1953; 2225: 71.
3. Bagnall AW. The value of chloroquine in rheumatoid disease - a four year study of continuous therapy. Can Med Assoc J 1957; 77: 182.
4. Scherbel AL, Harrison JW, Atdjiam M. Further observations on the use of 4-aminoquinoline compounds in patients with rheumatoid arthritis or related diseases. Cleve Clin Q 1958; 25: 95.
5. Cohen AS, Calkins E. A controlled study of chloroquine as an artirheumatic agent. Arthritis Rheum 1958; 1: 297.
6. Rinehart RE, Rosenbaum EE, Hopkins CE. Chloroquine therapy in rheumatoid arthritis. Northwest Med 1957; 15: 251.
7. Freedman A. Chloroquine and rheumatoid arthritis. Short term controlled trial. Ann Rheum Dis 1965; 152: 251.
8. Freedman A, Steinberg VL. Chloroquine in rheumatoid arthritis, a double blinded trial of treatment for one year. Ann Rheum Dis 1960; 19: 243.
9. Popert AJ, Meigers AKE, Sharp J, Bier F. Chloroquine diphosphate in rheumatoid arthritis: a controlled study. Ann Rheum Dis 1961; 20: 18.
10. Hamilton EBD, Scott JT. Hydroxychloroquine sulfate (plaquenil) in the treatment of rheumatoid arthritis. Arthritis Rheum 1962; 5: 502.
11. Mainland D, Sutcliff MI. Hydroxychloroquine sulfate in rheumatoid arthritis, a six month, double blind trial. Bull Rheum Dis 1957; 13: 287.
12. Pavelka Jr K et al. Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dosage regimens. Ann Rheum Dis 1989; 48: 542-546.
13. Dwosh IL et al. Azathiaprine in early rheumatoid arthritis: comparison with gold and chloroquine. Arthritis Rheum 1977; 20: 685-692.
14. Bunch TW, O'Duffy JD, Tompkins RB, O'Fallon WH Controlled trial of hydroxychloroquine and d-penicillamine singly and in combination in the treatment of rheumatoid arthritis. Arthritis Rheum 1984; 27: 267-76.
15. Fowler PD, Shadforth MF, Crook PR, Lawton A. Report on chloroquine and dapsone in the treatment of rheumatoid arthritis: a 6 month comparative study. Ann Rheum Dis 1984; 43: 200.
16. Bird HA et al. A single blind comparative study of auranofin and hydroxychloroquine in patients with rheumatoid arthritis. Clin Rheumatol 1984; 3 (Suppl 1): 57.
17. Van der Heijde DM et al. Effects of hydroxychloroquine and sulphasalazine on the progression of joint damage in rheumatoid arthritis. Lancet 1989; 1: 1036.
18. Felson DT, Anderson JJ, Meenan RF. Use of short-term efficacy/ toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metanalysis of published clinical trials. Arthritis Rheum 1992; 35: 1117-1125.
19. Davis MJ et al. Should disease modifying agents be used in mild rheumatoid arthritis? Br J Rheumatol 1991; 30: 451-454.
20. Youssef W, Yan A, Russell AS. Palindromic rheumatism: a response to chloroquine. J Rheumatol 1991; 18: 35-37.
21. Kay EA, Pullar T. Variations among rheumatologists in prescribing and monitoring of disease modifying artirheumatic drugs. Br J Rheumatol 1992; 31: 477-483.
22. Bernstein HN. Ocular safety of hydroxychloroquine. Ann Opthalmol 1991; 23: 292-296.